arrow
M

Mafalda Raposo

i3s instituto de investigacao e inovacao em saude
H指数:17
被引数:1,024

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-nucleotide polymorphism–directed design of allele-specific antisense oligonucleotides for spinocerebellar ataxia type 3

单核苷酸多态性指导下的脊髓小脑共济失调3型等位基因特异性反义寡核苷酸设计

2026-10-210
PRE
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort

脊髓小脑共济失调3型突变携带者在ESMI队列中的用药模式

2025-10-170
OA
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3
2024-12-120
OAAI
Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease
2024-04-010
OAAI
Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3

牛磺熊去氧胆酸在脊髓小脑共济失调3型临床前模型中的糖皮质激素受体依赖性治疗效果

2024-03-015
OAAI
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3

脊髓小脑性共济失调3型的阶段依赖性生物标志物变化

2023-12-058
OAAI
Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3

血液转录组测序确定能够跟踪脊髓小脑性共济失调3型疾病阶段的生物标志物

BRAIN
IF11.7
2023-04-184
OA
A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia

用于共济失调生物标志物研究的血液和脑脊液收集和处理的标准化协议

2023-03-292
OAAI
Novel Machado-Joseph disease-modifying genes and pathways identified by whole-exome sequencing

通过全外显子组测序鉴定的新型machado-joseph疾病修饰基因和途径

2022-01-018
OAAI
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood

多谷氨酰胺扩展Ataxin-3: 外周血中脊髓小脑性共济失调3型的目标参与标志物

2021-08-1615
OAAI
Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease

全基因组关联研究确定了改变machado-joseph病发病年龄的遗传因素

2020-03-2315
OAAI
DNA REPAIR PATHWAYS AS A COMMON GENETIC MECHANISM MODULATING THE AGE AT ONSET IN POLYGLUTAMINE DISEASES
2016-09-130
PREAI